In B16a melanoma cells, protein kinase-C-a (PKCa) is immunomorphologically associated with cytoplasmic vesicles in addition to the previously observed locations (plasma membrane, cytoskeleton, nudeus), as detected with monoclonal antibody (MAb) MC3a. Subcellular fractionation indicated that the authentic ~O -K D protein as well as PKC activity can be detected in several particulate fractions except for L2, which contains dense lysosomes. The highest PKC activity is associated with the cytosol-ultralight vesicles and the L1 fraction (containing plasma membrane, endosome, and the Golgi apparatus). Both of these fractions contained the fluid-phase endocytosis marker peroxidase, indicating that PKCa, in addition to other subcellular structutes, is most probably associated with endosomal membranes in B16a melanoma c e k (JHsruchem Cyfdem &:177-182,19%) 
Introduction
Protein kinases (PKs) comprise the effector elements of most of the signaling pathways and include CAMP-dependent PK and cGMP dependent PK (PKA/G), PKC, myosin heavy chainllight chain (MLCIMHC), mitogen-activated kinases, and PTK (1). Protein kinase-C is the effector element of the signaling pathway which involves the phospholipase (PL) Cy-inositol cycle or PLD activation as the signal amplification system. In both cases, the second messenger is diacyl-glycerol (DAG) acting on the regulatory domain of PKC (2) . In addition to DAG, kinase activity of PKC requires the activation of PLA2 and the subsequent production of various lipids, among them arachidonic acid (AA) metabolites. In addition, Ca++ is released from its intracellular pool (2) . PKC can be found in several isoforms which can be grouped as classical (a, B, y ) new (6, E, v, o), and atypical forms (1, h, () (2). Each group contains at least one isoform that is evenly distributed among tissues, whereas other isoforms may show tissue specificity. Cell fractionation and immunolocalization studies have indicated that PKC can be found in the cytosol (2), lipid membranes (2), cytoskeleton  (3,4) , and in the cell nucleus ( 5 ) It is suggested that different isoforms of PKC may have not only tissue but also subcellular specificity; consequently, their substrates may vary accordingly (2). PKC was shown to be involved in malignant transformation as well as in tumor progression (6) . The aim of the present study was to localize PKC in Bl6a melanoma cells. This cell type expresses only one isoform of PKC (i.e., the PKCa) (7), which translocates from the cytosol to the cell membrane after artificial or physiological stimulation with TPA or 12-(S)-HETE; the latter is a lipqgenase metabolite of AA (8) . We have localized PKCa in Bl6a melanoma cells using commercially available antibodies. Association of PKCa with the tumor cell membrane and the cytoskeleton will be discussed in another report (9) . In the present study, we report a new localization of PKCa in tumor cells, i.e., to the cytoplasmic vesicles that correspond in part to the endosomal compartment.
Materials and Methods
Bl6a murine melanoma cell cultures were prepared and maintained as described earlier (IO). Adherent cells were stimulated in situ with TPA (50 mM for 15 min) or 0.1 mM 12-(S)-HETE, 12-(R)-HETE, or 13-(S)-HODE (lipoxygenase metabolites) for 15 min in serum-free MEM to activate and translocate PKC (8) .
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In Vivo Labeling of the Endocytotic Compartment
Adherent tumor cells were incubated with 1 mg/ml horseradish peroxidase (Polyscience; Warrington, PA) in serum-free culture medium for 15 min and then were washed with medium and processed for subcellular fractionation.
Immunolabeling of PKCa
Fixations. Adherent tumor cells were fixed with MetOH for 7 min and acetone for 10 sec at -ZO'C, then were washed in PBS three times (5 min each). Alternatively. tumor cells were fixed in 4% paraformaldehyde-PBS for 10 min, followed by extraction with 0.5% Triton-HBSS for 2 min, both performed at room temperature. Cells then were incubated with nonimmune goat IgG diluted 1:2 in HBSS for 30 min to block nonspecific binding sites, washed in 1 x HBSS, and incubated with MAb MC3a, which recognizes the regulatory domain of PKCa (Seikagaku America; Rockville, MD) (11) (diluted 1:1000), MAb 1.9 (Gibco BRL; Gaithersburg, MD) (12) recognizing the homologue regions of the catalytic domain in PKC isoforms (diluted 1:100), MAb MC5 (Amersham; Arlington Heights. IL) which recognizes a trypsin-sensitive domain between the regulatory and catalytic domain of PKCa (13) (diluted 1:100), MAh 05-154 which recognizes a denaturation-sensitive regulatory domain of PKCa (UBI; Lake Placid, NY) (14) (diluted 1:lOO) in HBSS-4% BSA for 60 min at 37". The bound antibody was developed with antimouse IgG-biotin (goat) (Boehringer; Mannheim, Germany) diluted 1:50 in HBSS-4% BSA for 30 min and streptavidin-Tm Red (Amersham) diluted 1:lOO in HBSS-4% BSA for 30 min.
Double Labeling of PKCa and Vimentin
Adherent tumor cells were fixed with MetOH and acetone as described above and were washed in PBS three times for 5 min. Before labeling, cells were incubated with nonimmune goat serum diluted 1:2 in HBSS for 30 min. Vimentin was detected with rabbit antivimentin IgG (Sigma; St Louis, MO) diluted 1:50 in HBSS for 60 min. The bound rabbit IgG was detected with FIX-labeled goat antirabbit IgG (1:SO dilution) for 30 min. This was followed by labeling for PKCa with MAbl.9 as above.
Double Labeling of PKCa and Vinculin
Adherent tumor cells were fixed with paraformaldehyde and permeabilized by Triton X-100 and were blocked by nonimmune goat IgG as above. Cells were then labeled for 60 min with rabbit antivinculin IgG (Boehringer) diluted 1:lOO in HBSS. The bound rabbit IgG was detected with antirabhit F I X conjugate (k50 dilution; Sigma). After three washings in HBSS. PKCa was detected by using MAb MC5 as above.
Micrographs were taken with a Nikon epifluorescence microscope using a GH-2A filter system and Kodak X-Omat 400 b/w film.
Subcellular Fractionation and PKC Actiuity Assay
Subcellular fractionation of Bl6a cells was performed according to our previously described protocol (15.16). Adherent tumor cells (10-15 x lo6) in culture were scraped into 2 ml of homogenization buffer (250 mM sucrose-25 mM HEPES-1 mM EDTA, pH 7.5) at 4'C and were homogenized with a Dounce glass homogenizer (15 passes). The homogenate was centrifuged (a) at 530 x g for 11 min to obtain the nuclear pellet, which was not analyzed further, (b) at 6800 x g for 7 min to obtain the "heavy" mitochondrial pellet, (c) at 15,100 x g for 19 min to obtain the "light" mitochondrial pellet, and (d) at 1~, 0 0 0 x g for 60 min, where the resulting supernatant was considered to represent cytosol and ultralight vesicles. The "light" mitochondrial pellet was further purified by density gradient centrifugation on 30% (v/v) iso-osmotic Percoll prepared in homogenization buffer, and two visible bands (L1 and L2) were obtained. Identification of fractions containing endosomes was achieved by detecting the internalized peroxidase. Fractions (1 pg) were dot-blotted onto nitrocellulose membrane and peroxidase activity was detected by using the ECL Western blot detection reagents (Amersham) according to the manufacturer's protocol.
Determination of PKC activity, gel electrophoresis, and immunoblotting of PKCa were performed as described earlier (8, 17) .
Results

Immunocytochemistry
All four commercially available anti-PKCa antibodies were able to detect PKC of Bl6a cells in the cytosol (data not shown) and at the plasma membrane (after paraformaldehyde-Triton X-100 fixation) (lible 1; Figure la ). MAb MC5 detected PKC associated with stress fibers at focal adhesions (using Triton X-100 permeabilization) and showed some co-localization with the focal adhesion protein vinculin (Figures 1b and IC 
Localization of PKCa to Cytoplasmic Vesicles
In MetOH-fixed cells but not in paraformaldehyde-fixed and Triton X-100-permeabilized cells (data not shown), MAb MC3a revealed a unique localization of PKCa in adherent Bl6a cells ( Figures  2a and 2b) . The Texas Red label was associated predominantly with perinuclear vesicles of various sizes, whereas smaller vesicles were occasionally found in the peripheral cytoplasm. TPA stimulation of the adherent cells (50 nM for 15 min) induced significant rearrangement of the cytoplasmic PKCa-positive structures. The vesicles became translocated from the perinuclear zone to the cell periphery (Figures 2c and 2d ). Similar to TPA, the lipoxygenase metabolite 12-(S)-HETE (0.1 pM for 15 min) (8) also induced dispersion of the PKC-positive vesicles in the cytoplasm (Figures 2e  and 2f ).
Identz3cation of PKCa in Subcellular Fractions of BlGa Cells
To prove the association of PKCa with cytoplasmic vesicles in Bl6a cells, subcellular compartments were fractionated as previously described (15~6). The characterization of various vesicular compartments in this cell line was described earlier using biochemical and morphological techniques (15, 16) .
Proteins were separated by SDS-PAGE and PKCa was identified by Western blotting. All fractions contained intact PKCa protein (80 m) (Figure 3A) except for the L2 lysosomal fraction. The highest intensity could be seen in the 100,000 x g cytosol-ultralight vesicle fraction, indicating a significantly higher amount of PKCa protein in that fraction compared to the L1 (plasma membranes and endosomes) and to the "heavy" mitochondrial fractions (mitochondria aiid dense lysosomes).
Measurement of PKC activity in the subcellular fractions of Bl6a cells revealed that the fractions had variable PKC activity, with the lysosomal fraction demonstrating minimal activity ( Figure 3B ). The relative ratio of the PKC activity in subcellular fractions (cytosol-ultralight vesicle > L1 > "heavy" mitochondria > L2) paral- lclcd thc rclativc PKCa protcin found with Wcstcrn blotting (cytosol-ultralight vcsiclcs > hcavy mitochondria = L1 > LZ) (Figurc 3A) . Cytoplasmic stmcturcs with vcsicular morphology at thc light microscopic level may bclong to various cytoplasmic organelles such as endoplasmic reticulum, Golgi nctwork. lysosomes. and the cndosomal systcm. We used a fluid-phase cndocytosis marker. HRP (1 mglml) to label those subcellular fractions that belong to the cndosomal-trans-Golgi network. Bl6a cclls wcrc incubatcd at 37'C with HRP for various time periods (15-60 min) and the intcrnalizcd ligand was rcvcalcd by DAB reaction (data not shown). The 5-15-min intcrnalization of HRP into Bl6a cells labeled prcdominantly thc cndosomal compartment. whereas thc longcr incubations (30-60 min) loaded the marker to its final destination. i.e.. to lysosomes. Aftcr 15-min intcrnalization of HRP into B16a cells, subcellular fractions were prepared as in the case of Wcstcrn blotting of PKCa ( Figure 3A) and aliquots were dot-blottcd onto the nitroccllulosc. Aftcr revealing the peroxidase activity in the sub-cellular fractions. wc found a variable amount of the cndocytoscd markcr in all thc subcellular fractions cxccpt for the lysosomcs (LZ) ( Figure 3C ). The cytosol-ultralight vesiclc and thc L1 fractions exhibitcd the highest peroxidase activity. which indicates that these fractions contain thc majority of the cndosomal system. Bccausc both fractions contain PKC protein and activity, it is suggested that cndosomcs arc associatcd with PKCa in Bl6a melanoma cells.
Discussion
Thc subcellular fractionation technique applicd hcre provides isolation of cytoplasmic organelks by using the combination of diffcrcntial ccntrifugation and Pcrcoll density gradicnt separation (15.16). Using this technique on Bl6a cells, the fractions obtained contain thc following organelles. The L1 fraction (1.045 glml) is the only one which contains plasma mcmbrane but also contains O.I-l-mm vesicles that may belong to the Golgi system. The L2 fraction (1.07 glml) contains dcnsc lysosomes, multivesicular bodies, and endoplasmic reticulum. The "hcavy" mitochondrial fraction (1.1 1 glml) contains both mitochondria and dcnsc lysosomcs.
The 1~,~ x g supernatant of the LM.2 fractions contains cytosol and ultralight vcsiclcs (<0.1 p i ) (15.16) . Bccausc the cndosomal compartment comprises a significant amount of the cytoplasmic mcmbrancs, wc used HRP as a fluid-phasc endocytosis marker to identify fractions that contain clcmcnrs of this system in Bl6a cells. Thesc data indicated that thc cytosol-ultralight vesicle and the L1 fractions contain the majority of thc cndosomal system. PKC activity and protcin wcrc dctcctcd in all fractions except for secondary lysosomes (LZ). This may indicate that PKCa is not associatcd with sccondary lysosomcs in Bl6a cells. However, the majority of thc PKC activity, as well as protein. was found in L1 and in thc cytosol-ultralight vcsiclc fractions, which contain the majority of the cndosomal compartment, as evidenced by pcroxidasc cndocytosis. This may indicate that PKCa is associatcd with cndosomcs in the cytoplasm of Bl6a cclls. Howevcr. thc L1 fraction contains plasma mcmbranc and Golgi clcmcnts also, but not thc components of thc endoplasmic rcticulum (based on the prescncc of Na, K-ATPasc. galactosyl transferasc activity, and the lack of glucose-6-phosphatase activity) (15~6). Thcrdorc, wc concludc that PKCa may also be associated with certain Golgi vcsiclcs in Bl6a cclls in addition to thc cndosomcs.
Using biochemical and immunomorphological techniques, PKC has bccn localized previously to four subccllular sites: (a) cytoplasm (L3.8); (b) plasma mcmbranc (2, 3, 8) ; (c) strcss fibcn (3,4,18); and (d) intcrmcdiatc filamcnts (3.4). Furthcrmorc, PKCp was prcviously shown to be associatcd with the Golgi systcm in neuronal cells (19) . By comparing thc subcellular localization of PKCa in Bl6a cells using different commercially amilablc antibodies, we have obscrvcd all of thc prcviously described associations of this kinasc with cytoplasmic stmcturcs. i.e., association with plasma mcmbranc, strcss fibers at focal adhcsions. and intcrmcdiatc filaments (Table 1; Fig. 1 ). However, wc found another localization of PKCa that has not been reported previously in tumor cclls. i.e., association with cytoplasmic vesicles. Intcrcstingly, only one anti-PKCa MAb MC3a recognizing the regulatory domain (11). demonstrated such localization. Thc cytoplasmic tubulovcsicular structures contain lysosomes. cndosomes. multivesicular cndosomes. truns-Golgi network. or the so-called post-Golgi membranous organelles (20) and even endoplasmic reticulum (21). Association of PKC activity and protein with HRP-positive subcellular fractions and PKC localization to cytoplasmic vesicles suggest that the majority of PKCa-positive structures belong to the endosomal compartment. However, the size of the labeled vesicles and their location, i.e., association with the perinuclear Golgi area, as well as the association of PKC activity with the L1 fraction, which contains galactosyl transferase (15, 16) , might also indicate PKCa association with Golgi membranes as well in Bl6a cells, similar to PKCB in neurons (19) .
What could be the function of PKC in these compartments? Endosomes are cytoplasmic structures involved in receptor cycling and recycling processes (20). This compartment contains the secretory arm of receptor translocation from the Golgi zone as well as the location to which receptors internalize after ligand binding. Signal transduction usually takes place at the cell surface in the case of extracellular ligands. Therefore, the temporary association of the activated receptor with the elements of the signaling complex (transducers and effectors) may also take place at this location. For example, functional integrin a/p complexes are stored in cytoplasmic vesicles (22), where G-proteins also can be detected (23). Our data demonstrating PKCa association with endosomal vesicles and the Golgi system confirm previous findings in neurons (19) and may indicate the existence of a functional signaling complex in the cytoplasm in addition to the plasma membrane. Furthermore, we have shown that the stimulation of PKC in tumor cells, either with TPA or an arachidonic acid metabolite, 12-(S)-HETE (8), induced redistribution of PKC-positive vesicles from the perinuclear zone to the peripheral cytoplasm. Such a PKC-dependent centripetal vesicle translocation in tumor cells was described previously in the case of integrins (22), autocrine motility factor receptor (24). and the lysosomal enzyme cathepsin B (25). This suggests that tumor cell PKC may have important functions in regulating organelle translocation-dependent events, such as enzyme secretion or receptor translocation to the plasma membrane.
